Authors: Christos D Karkos Dimitrios M Kapetanios Prodromos Th Anastasiadis Foteini S Grigoropoulou Thomas E Kalogirou Ioakeim T Giagtzidis Konstantinos O Papazoglou
Publish Date: 2015/03/24
Volume: 38, Issue: 6, Pages: 1416-1424
Abstract
The vascular unit database was interrogated to identify all AAA patients who underwent endovascular repair with the Anaconda™ device between March 2007 and June 2014 The perioperative shortterm and midterm outcome was recorded focusing on complications and reinterventionsSixtyeight patients had been treated during the study period Seven of these were symptomatic one presented with an inflammatory aneurysm and five presented with a ruptured AAA The primary and the assisted primary technical success were 867 and 971 respectively There was no 30day mortality in the elective or symptomatic group but two of the ruptured AAA patients died During a mean followup of 29 months range 1–87 14 patients died none from aneurysmrelated causes A total of 11 endoleaks 175 were detected in 10 patients during followup 1 type Ia 4 type Ib 6 type II 4 of which required reintervention all for type Ib endoleak Two iliac limbs occluded during the followup The estimated overall survival endoleakfree survival and reinterventionfree survival probability were 882 784 and 834 at 1 year 859 738 and 789 at 2 years and 806 713 and 705 at 3 years respectively
Keywords: